Article
In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different β-Lactam Resistance Phenotypes.
Antimicrobial agents and chemotherapy - 1 Sept 2018
Robin Frédéric, Auzou Michel, Bonnet Richard, Lebreuilly Romain, Isnard Christophe, Cattoir Vincent, Guérin François
Abstract excerpt
The study evaluated the in vitro activity of ceftolozane-tazobactam (C/T) against 94 unique clinical isolates of Enterobacter cloacae complex (ECC). No difference was observed according to the ECC cluster. The in vitro activity greatly varied depending on the β-lactamase-producing profile: 100%, 67%, and 19% of wild-type, extended-spectrum β-lactamase (ESBL)-producing, and AmpC-overproducing strains,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
